CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK

Summary

The industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the UK. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by The team of industry experts.

The value of the UK pharmaceutical market increased from 13.2bn ($20.3bn) in 2010 to 19.6bn ($25.9bn) in 2017, at a compound annual growth rate (CAGR) of 5.9% in the terms of GBP and 3.5% in the terms of US$. The market is expected to reach 26.2bn ($30.9bn) in 2022. The increased usage of personalized medicines, incorporating digital technology into drug development and accelerating drug access pathway, high disease burden and rise in elderly population are the main driving factors of pharmaceutical market. In 2015, the medical device market in the UK was worth $17.8 billion, which increased to $19.1 billion in 2017 at a CAGR of 3.6%. It is expected to grow at a CAGR of 4.1% from $19.8 billion in 2018 to $26.3 billion in 2025. The main segments were in vitro diagnostics, ophthalmic devices, cardiovascular devices, wound care devices and orthopedic devices. The development in personalized or precision medicines, incorporation of genetic sequencing and personal genome data, is revolutionizing the approach medical practitioners and pharmaceutical industries are undertaking for the disease treatment.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the UK, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (AstraZeneca, GlaxoSmithKline, Merck, Novartis and Pfizer) and profiles and SWOT analyses of the major players in the medical device market (Siemens, Roche, DePuy, Essilor and Smith & Nephew)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of the UK
- Porters five forces analysis for pharmaceutical and medical devices market of the UK
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the UK healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the UK healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the UK healthcare market.

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List Of Tables


Table 1: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2016 26
Table 2: Medical Device Market, UK, Revenue by Segment ($bn), 2017 46
Table 3: InVitro Diagnostics Devices Market, UK, Revenue and Market Share of Major Players 47
Table 4: Ophthalmic Devices Market, UK, Revenue and Market Share of Major Players 48
Table 5: Cardiovascular Devices Market, UK, Revenue and Market Share of Major Players 49
Table 6: Wound Care Devices Market, UK, Revenue and Market Share of Major Players 50
Table 7: Orthopedic Devices Market, UK, Revenue and Market Share of Major Players 51
Table 8: Market Access, Forecasts and Profile Of Annual Payment Percentages, UK, 2014-2018 94
Table 9: Patent Fees ($), 2018, UK 116
Table 10: Trademark Fees ($), 2018, UK 119
Table 11: Clinical Trials Application Fees ($), 2018, UK 122
Table 12: Clinical Trials Application Fees ($) for Medical Devices, 2018, UK 122
Table 13: Trade Associations, UK 144
Table 14: Trade Fairs, UK 145

List Of Figures


Figure 1: Pharmaceutical Market, UK, Revenue, 2015-2022 8
Figure 2: Medical Device Market, UK, Revenue, 2015-2020 8
Figure 3: UK Brexit Timeline, UK, 2018 12
Figure 4: Number of Deals (2017-2018) 14
Figure 5: 2017-2018 Deal Overview By Region 14
Figure 6: Country Profile, UK, 2018 16
Figure 7: Pharmaceutical Market, UK, Revenue, 2010-2017 18
Figure 8: Pharmaceutical Market, UK, Revenue Forecast, 2018-2022 18
Figure 9: Pharmaceutical Market, UK, Pharmaceutical Exports 19
Figure 10: Pharmaceutical Market, UK, Top Export Partners 19
Figure 11: Pharmaceutical Market, UK, Pharmaceutical Imports 20
Figure 12: Pharmaceutical Market, UK, Top Import Partners 20
Figure 13: Pharmaceutical Market, UK, Supply Channels 21
Figure 14: Pharmaceutical Market, UK, Sales of OTC drugs by Major Therapeutic Segments, 2018 25
Figure 15: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class, 2016 26
Figure 16: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2016 26
Figure 17: Pharmaceutical Market, UK, Major Players 28
Figure 18: Medical Device Market, UK, Revenue, 2015-2020 45
Figure 19: Medical Device Market, UK, Revenue Forecast, 2021-2025 45
Figure 20: Medical Device Market, UK, Revenue by Segment, 2017 46
Figure 21: InVitro Diagnostics Devices Market, UK, Revenue 47
Figure 22: InVitro Diagnostics Devices Market, UK, Market Share of Major Players 47
Figure 23: Ophthalmic Devices Market, UK, Revenue 48
Figure 24: Ophthalmic Devices Market, UK, Market Share of Major Players 48
Figure 25: Cardiovascular Devices Market, UK, Revenue 49
Figure 26: Cardiovascular Devices Market, UK, Market Share of Major Players 49
Figure 27: Wound Care Devices Market, UK, Revenue 50
Figure 28: Wound Care Devices Market, UK, Market Share of Major Players 50
Figure 29: Orthopedic Devices Market, UK, Revenue 51
Figure 30: Orthopedic Devices Market, UK, Market Share of Major Players 51
Figure 31: Diagnostic Market, UK, Revenue ($bn), 2015-2020 52
Figure 32: Diagnostic Market, UK, Revenue Forecast ($bn), 2021-2025 52
Figure 33: Medical Device Market, UK, Revenue of Major Players, 2016 54
Figure 34: Deal Value and Deal Count, Pharmaceutical Market, UK, 2017-2018 74
Figure 35: Deal Value and Deal Count Quarterly, Pharmaceutical Market, UK, 2017-2018 74
Figure 36: Deal Value and Deal Count Sub-types, Pharmaceutical Market, UK, 2017-2018 74
Figure 37: Top Five Therapy Area by Deal Value, Pharmaceutical Market, UK, 2017-2018 75
Figure 38: Top Five Therapy Area by Deal Number, Pharmaceutical Market, UK, 2017-2018 75
Figure 39: M&A Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018 75
Figure 40: Venture Financing Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018 75
Figure 41: Private Equity Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018 75
Figure 42: Medical Device Market Deals, UK, 2017-2018 (by Deal Value, $m) 76
Figure 43: Medical Device Market Deals, UK, 2017- 2018 (by Deal Count) 76
Figure 44: Medical Device Market Deals Share (by Deal Count), UK, 2017-2018 76
Figure 45: Medical Device Market Deals Share (by Deal Value), UK, 2017-2018 76
Figure 46: Medical Device, Top Therapy Area by Deal Value, UK, 2017-2018 77
Figure 47: Medical Device, Top Therapy Area by Deal Number, UK, 2017-2018 77
Figure 48: M&A Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number) 77
Figure 49: Venture Financing Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number) 77
Figure 50: Private Equity Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number) 77
Figure 51: Healthcare Market, UK, Overview of Health System, 2018 82
Figure 52: Overview of Finance Flow, UK, 2018 83
Figure 53: NHS Departmental Expenditure Limit ($bn), UK, 2015-2021 84
Figure 54: Market Access, Reimbursement Schemes, UK, 2016 88
Figure 55: OOP Expenditure (% of Total Expenditure on Health), UK, 2010-2017 91
Figure 56: Annual Average Rates of Price Change (%), Medicines Price Index, UK, 2010-2017 91
Figure 57: Market Access, MHRA Structure, UK, 2018 96
Figure 58: Centralized Procedure, UK, 2018 101
Figure 59: Centralized Procedure, EU, 2018 102
Figure 60: Decentralized Procedure, EU, 2018 103
Figure 61: Mutual Recognition Procedure, UK, 2018 104
Figure 62: Life Cycle of Medical Device, UK, 2018 105
Figure 63: Conformity Assessment of Class I Medical Devices, EU, 2018 109
Figure 64: Conformity Assessment of Class IIa Medical Devices, EU, 2018 110
Figure 65: Conformity Assessment of Class IIb Medical Devices, EU, 2018 111
Figure 66: Conformity Assessment of Class III Medical Devices, EU, 2018 112
Figure 67: Licensing Procedure for Pharmaceutical Manufacturing, UK, 2018 113
Figure 68: Patent Approval Process, UK, 2018 115
Figure 69: European Patent Approval Process, EU, 2017 117
Figure 70: Unitary Patent Approval Process, EU, 2017 118
Figure 71: Trademark Approval Process, UK, 2018 119
Figure 72: Clinical Trial Authorization (CTA) Application Flowchart, 2017, UK 121
Figure 73: Market Access, UK, Clinical Trial Regulation Process for Medical Devices, 2018 123
Figure 74: Market Access, Regulatory Changes in the UK Before and After Brexit, 2018 128
Figure 75: Number of Hospitals, UK, 2010-2017 136
Figure 76: Diagnostic Equipment (per Million Population), UK, 2010-2017 136
Figure 77: Hospital Beds (per 1,000 Population), UK 137
Figure 78: Psychiatric Hospital Beds (per 1,000 Population), UK 137
Figure 79: Life Expectancy, 2010-2017, UK 138
Figure 80: Immunization Rate (%), 2010-2017, UK 138
Figure 81: PM2.5 (g per m3), UK, 2010-2017 139
Figure 82: CO2 Emissions (Million Tons), UK, 2010-2017 139
Figure 83: Physicians (per 1,000 Population), UK, 2010-2016 140
Figure 84: Nurses (per 1,000 Population), UK, 2010-2016 140
Figure 85: Dentists (per 1,000 Population), UK, 2010-2016 140
Figure 86: Pharmacists (per 1,000 Population), UK, 2010-2016 140
Figure 87: Major Causes of Mortality (per 1,000 Population), UK, 2016 141
Figure 88: Major Causes of Male Mortality, UK, 2016 141
Figure 89: Major Causes of Female Mortality, UK, 2016 141
Figure 90: Disability-Adjusted Life Years by Major Disease (000), UK, 2016 141
Figure 91: Healthcare Expenditure as Percentage of GDP (%), UK, 2010-2017 142
Figure 92: Public-Private Share (%), UK, 2010-2017 142
Figure 93: Major Components of Healthcare Spending (%), UK, 2016 143
Figure 94: Opportunities and Challenges, UK 147

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - IndiaIt, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India . The report is an essential

USD 1995 View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - ChinaThe industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China . The report is an essential source

USD 1995 View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - IndiaIt, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India . The report is an essential

USD 1995 View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - ChinaThe industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China . The report is an essential source

USD 1995 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available